发明名称 SUBSTITUTED TRIAZINE KINASE INHIBITORS
摘要 The present invention provides substituted 1,3,5-triazine compounds of Formula (I): wherein X, Y and Z are independently selected from the group consisting of CH and N; wherein m is an integer from 2 to 5; wherein X, Y and Z include at least one CH atom and at least one N atom; and, wherein a N atom may simultaneously occupy only the X and Z positions; R 1 is selected from the group consisting of hydrogen and NH 2 ; and, R 2 is selected from the group consisting of phenyl (wherein phenyl is substituted with one substituent selected from the group consisting of halogen and heterocyclyl) and 1,4-benzodioxinyl; and pharmaceutically acceptable salts thereof as kinase inhibitors and a method for treating or ameliorating a kinase mediated disorder.
申请公布号 EP2256108(B1) 申请公布日期 2016.03.23
申请号 EP20100176670 申请日期 2003.07.18
申请人 JANSSEN PHARMACEUTICA NV 发明人 KUO, GEE-HONG;DEANGELIS, ALAN;WANG, AIHUA;ZHANG, YAN;EMANUEL,, STUART L;MIDDLETON, STEVE A
分类号 C07D251/22;A61K31/53;A61P19/02;A61P35/00;A61P35/02;C07D401/04;C07D401/14;C07D403/04;C07D403/12;C07D405/04;C07D405/14 主分类号 C07D251/22
代理机构 代理人
主权项
地址